Female Sexual Dysfunction: Pharmaceutical Sham or an Opportunity for Empowerment? Meghan Murphy explores this controversial topic with Dr Thea Cacchioni, professor of Sociology and Women’s & Gender Studies. Dr Cacchioni has taught at the University of British Columbia in Vancouver and the Okanagan and recently gave a talk, as part of the Ruth Wynn Woodward Speaker Series at SFU entitled: “Sex, Gender & Pharmaceuticals: The Search for the ‘Pink’ Viagra.” On June 18th, 2010 she will testify at an FDA advisory hearing against the approval of Flibanserin, a drug proposed to treat ‘hypo-active sexual desire disorder’ in pre-menopausal women.